Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40)

Journal of Neuroscience

Volumn 16, Issue 24, 1996, Pages 7910-7919

  Backstrom, Jon R ^a   Lim, Giselle P ^a   Cullen, Michael J ^a   Tökés, Zoltán A ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Cancer Research Laboratories   (United States)

Author keywords

Alzheimer's disease; amyloid cleavage; amyloid plaques; gelatinase; matrix metalloproteinases; protease activation

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN [1-40]; GELATINASE B; PHENYLMERCURIC ACETATE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029852887     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-24-07910.1996     Document Type: Article

References (47)

1. Abraham CR, Selkoe DJ, Potter H (1988) Immunochemical identification of the serine proteinase inhibitor, alpha-1-antichymotrypsin, in the brain amyloid deposit of Alzheimer's disease. Cell 52:487-501.
2. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 151:1105-1113.
3. Backstrom JR, Tökés ZA (1995) The 84 kDa form of human matrix metalloproteinase-9 (MMP-9) degrades substance P and gelatin. J Neurochem 64:1312-1318.
4. Backstrom JR, Miller CA, Tökés ZA (1992) Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem 58:983-992.
5. Breitner JCS, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44:227-232.
6. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
7. Davies DC, Horwood N, Isaacs SL, Mann DM (1992) The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation. Acta Neuropathol (Berl) 83:510-517.
8. r 94,000 gelatin-degrading metalloproteinase induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Cancer Res 50:1113-1120.
9. Devarajan P, Johnston JJ, Ginsberg SS, Van Wart HE, Berliner N (1992) Structure and expression of neutrophil gelatinase cDNA. J Biol Chem 267:25228-25232.
10. Ennis BW, Matrisian LM (1994) Matrix degrading metalloproteinases. J Neurooncol 18:105-109.
11. Esch FS, Keim PS, Beattie EC, Blacher RW, Cultwell AR, Olsterdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122-1124.
12. Fulcher IS, Kenny AJ (1983) Proteins of the kidney microvillar membrane. The amphipathic form of endopeptidase purified from pig kidneys. Biochem J 211:743-753.
13. Goldberg GI, Strongin A, Collier IA, Genrich LT, Marmer BL (1992) Interaction of 92 kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267:4583-4591.
14. Heussen C, Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102:196-202.
15. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL (1985) Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493-2500.
16. Horikoshi T, Danenberg K, Volkenandt M, Stadibauer T, Danenberg PV (1993) Quantitative measurement of relative gene expression in human tumors. In: Methods in molecular biology, Vol 15 (White BA, ed), pp 177-188. Totowa, NJ: Humana.
17. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
18. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530-532.
19. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tökés ZA (1996) Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis (ALS) patients. J Neurochem 66:251-259.
20. Matsas R, Fulcher IS, Kenny AJ, Turner AJ (1983) Substance P and [leu]enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 80:3111-3115.
21. McDermott JR, Gibson AM (1991) The processing of Alzheimer A4/β-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide. Biochem Biophys Res Commun 179:1148-1154.
22. McKhann G, Drachman D, Holstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCD-S-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
23. Miyazaki K, Hasegawa M, Funahashi K, Umeda M (1993) A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362:839-841.
24. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50:6162-6170.
25. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H (1992) Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 285:603-611.
26. Murphy G, Bretz U, Baggiolini M, Reynolds JJ (1980) The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J 192:517-525.
27. Netzel-Arnett S, Sang Q-X, Moore WGI, Navre M, Birkedal-Hansen H, Van Wart HE (1993) Comparative sequence specificities of human 72-and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 32:6427-6432.
28. Ogata Y, Enghild JJ, Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581-3584.
29. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T (1992) Matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 267:21712-21719.
30. Oltersdorf T, Fritz LC, Schenk DB, Lieberburg I, Johnson-Wood KL, Beattie EC, Ward PJ, Blacher RW, Dovey HF, Sinha S (1989) The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341:144-147.
31. Papstoitsis G, Siman R, Scott R, Abraham CR (1994) Identification of a metalloprotease from Alzheimer's disease brain able to degrade the β-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry 33:192-199.
32. Peppin GJ, Weiss SJ (1986) Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 83:4322-4326.
33. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid m RNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525-527.
34. Potter H, Abraham CR, Dressler D (1991) The Alzheimer amyloid components α1-antichymotrypsin and β-protein form a stable complex in vitro. In: Alzheimer's disease: basic mechanisms, diagnosis, and therapeutic strategies (Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM, eds), pp 275-279. New York: Wiley.
35. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R (1994) Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Commun 205:1755-1761.
36. Schönlein C, Löffler J, Huber G (1994) Purification and characterization of a novel metalloprotease from human brain with the ability to cleave substrates derived from the N terminus of β-amyloid protein. Biochem Biophys Res Commun 201:45-53.
37. Selkoe DJ (1994) Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 17:489-517.
38. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
39. Shah SV, Baricos WH, Basci A (1987) Degradation of human glomerular basement membrane by stimulated neutrophils. J Clin Invest 79:25-31.
40. Simmons LK, May PC. Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieherburg I, Becker GW, Brems DN, Li WY (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
41. Sisodia SS, Koo EH, Bayreuther K, Unterbeck A, Price DL (1990) Evidence that β-amyloid in Alzheimer's disease is not derived by normal processing. Science 248:492-495.
42. 73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87:364-368.
43. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528-530.
44. Van Nostrand WE, Wagner SL, Suzuki M, Choi BH, Farrow JS, Geddes JW, Cotman CW, Cunningham DD (1989) Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid β-protein precursor. Nature 341:546-549.
45. Vissers CM, Winterbourn CC (1988) Activation of human neutrophil gelatinase by endogenous serine proteinases. Biochem J 249:327-331.
46. Wilhelm SM, Collier IE, Mariner BL, Eisen AZ, Grant GA, Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221.
47. Yamada T, Miyazaki K, Koshikawa N, Takahashi M, Akatsu H, Yamamoto T (1995) Selective localization of gelatinase A, an enzyme-degrading beta-amyloid protein, in white matter microglia and in Schwann cells. Acta Neuropathol (Berl) 89:199-203.